Working… Menu
Trial record 1 of 1 for:    aflacST1603
Previous Study | Return to List | Next Study

Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03507491
Recruitment Status : Recruiting
First Posted : April 25, 2018
Last Update Posted : July 21, 2020
Celgene Corporation
Information provided by (Responsible Party):
Thomas Cash, MD, Emory University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : May 2022